Genomic Translation for ALS Clinical Care

Investigator: Stanley Appel, MD

Study Coordinator: Sharon Halton

Status: Enrolling

ClinicalTrials.gov Number: NCT02795897

Phone: 713.441.3420

Protocol Number: Pro00015886

Description

The purpose of the this study to look for abnormal genes and gene expression profiles that help determine why a person develops amyotrophic lateral sclerosis (ALS) and related motor neuron diseases (MND) and why their symptoms present and progress with a particular pattern. [NCT=n/a]
More to Explore